- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06425601
A Comparison of Silicone Versus Polyvinylchloride (PVC) Drains Following VATS Lobectomy
May 17, 2024 updated by: Boris Greif, MD, University Medical Centre Ljubljana
The Impact of Chest Drain Type on Pain, Drainage Efficacy and Short Term Outcome Following VATS Lobectomy for Lung Cancer: A Prospective Randomized Study Comparing Silicone Versus PVC Drains
The goal of this prospective randomized clinical trial is to compare the impact of the chest tube type on pain, chest drainage efficacy and early postoperative outcome following VATS lobectomy for lung cancer.
The main questions it aims to answer are:
- silicone chest drains are less painful compared to standard PVC drains?
- is there any difference in chest drainage efficacy and short term outcome between the two groups? Researchers will compare silicone chest drain group with PVC chest drain group to see if there is any difference in postoperative pain, chest drainage efficacy and short term outcome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- University Medical Centre Ljubljana
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- primary lung cancer eligible for VATS lobectomy by tumor board meeting
Exclusion Criteria:
- age under 18 years
- high risk of post-operative complications (ASA > 3, diffusion capacity for transfer factor (TLCO) or forced expiratory volume at one second (FEV1) ≤ 40%, cycle ergometry with oxygen consumption (VO2 max) < 15 ml/kg/min)
- tumors growing in parietal pleura
- extended lung resection diffuse
- previous surgery in the same hemithorax
- chronic pain
- chronic use of analgesics or sedatives
- surgical revision
- inability to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Silicone (SIL) group
For postoperative pleural space drainage a silicone coaxial drain of size French 24 (Redax Coaxial Drain, Redax S.p.A., Poggio Rusco Mantova, Italy) was used
|
Silicone chest tube used for pleural space drainage after VATS lobectomy
|
|
Active Comparator: PVC group
For postoperative pleural space drainage a standard polyvinyl chloride drain of size French 24 (Argyle, Covidien, Mansfield, USA) was used
|
Polyvinyl chloride chest tube used for pleural space drainage after VATS lobectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Analgesics consumption
Time Frame: 2 days
|
Amount of analgesics used first two days after the surgery was analyzed and reported in milligrams.
Higher scores mean a worse outcome.
|
2 days
|
|
Need for peroral analgesia after the chest tube removal
Time Frame: 2 days
|
Need for peroral analgesia at first, second and fourth week after chest tube removal was assessed and reported as frequency in number.
Higher scores mean a worse outcome.
|
2 days
|
|
Maximal inspiratory pressure
Time Frame: 2 days
|
Post-operative pain during the first two days after the surgery was analyzed by measuring the maximal inspiratory pressure (MIP) in cmH2O.
Higher scores mean a better outcome.
|
2 days
|
|
Maximal expiratory pressure
Time Frame: 2 days
|
Post-operative pain during the first two days after the surgery was analyzed by measuring the maximal expiratory pressure (MEP) in cmH2O.
Higher scores mean a better outcome.
|
2 days
|
|
Visual analogue scale
Time Frame: 2 days
|
Post-operative pain during the first two days after the surgery was analyzed by using the visual analogue scale (VAS).
Scale tittle was Visual Analogue Scale.
Minimum value on a scale was 0 and maximum value was 10.
Higher scores mean a worse outcome.
|
2 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of chest drainage
Time Frame: 1 month
|
The effectiveness of chest drainage was analyzed by assessing the duration of chest drainage in days.
Higher scores mean a worse outcome.
|
1 month
|
|
Pneumothorax rate on the day of surgery
Time Frame: First day
|
The effectiveness of chest drainage was analyzed by assessing the rate of pneumothorax (frequency in number) on chest x-ray on the day of surgery.
Higher scores mean a worse outcome.
|
First day
|
|
Pneumothorax rate after chest tube removal
Time Frame: 1 month
|
The effectiveness of chest drainage was analyzed by assessing the rate of pneumothorax (frequency in number) on chest x-ray after removal of the drain.
Higher scores mean a worse outcome.
|
1 month
|
|
Pleural effusion rate on the day of surgery
Time Frame: First day
|
The effectiveness of chest drainage was analyzed by assessing the rate of pleural effusion (frequency in number) on chest x-ray on the day of surgery.
Higher scores mean a worse outcome.
|
First day
|
|
Pleural effusion rate after chest tube removal
Time Frame: 1 month
|
The effectiveness of chest drainage was analyzed by assessing the rate of pleural effusion (frequency in number) on chest x-ray after removal of the drain.
Higher scores mean a worse outcome.
|
1 month
|
|
Subcutaneous emphysema rate
Time Frame: 1 month
|
The effectiveness of chest drainage was analyzed by assessing the rate of clinically expressed subcutaneous emphysema (frequency in number).
Higher scores mean a worse outcome.
|
1 month
|
|
Prolonged air leak rate
Time Frame: 1 month
|
The effectiveness of chest drainage was analyzed by assessing the rate of prolonged air leak over 5 days (frequency in number).
Higher scores mean a worse outcome.
|
1 month
|
|
Reintervention rate
Time Frame: 1 month
|
The effectiveness of chest drainage was analyzed by assessing the rate of reintervention (thoracentesis or chest drainage) after chest tube removal (frequency in number).
Higher scores mean a worse outcome.
|
1 month
|
|
Duration of hospital stay
Time Frame: 1 month
|
Early postoperative course was analyzed by assessing the duration of hospital stay (in days).
Higher scores mean a worse outcome.
|
1 month
|
|
Respiratory complication rate
Time Frame: 1 month
|
Early postoperative course was analyzed by assessing the rate of respiratory complications (frequency in number).
Higher scores mean a worse outcome.
|
1 month
|
|
Readmission rate
Time Frame: 1 month
|
Early postoperative course was analyzed by assessing the rate of readmission in the first month after drain removal (frequency in number).
Higher scores mean a worse outcome.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Boris Greif, UMC Ljubljana
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 30, 2020
Primary Completion (Actual)
August 10, 2023
Study Completion (Actual)
August 10, 2023
Study Registration Dates
First Submitted
May 8, 2024
First Submitted That Met QC Criteria
May 17, 2024
First Posted (Actual)
May 22, 2024
Study Record Updates
Last Update Posted (Actual)
May 22, 2024
Last Update Submitted That Met QC Criteria
May 17, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0120-445/2019/8
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Complications
-
Twin Cities Spine CenterAllina Health SystemRecruitingComplications, PostoperativeUnited States
-
Marmara UniversityHacettepe University; Cukurova University; Gazi University; Baskent University; Istanbul... and other collaboratorsNot yet recruitingComplications, PostoperativeTurkey
-
Syed HusainCompletedComplications, PostoperativeUnited States
-
Washington University School of MedicineNational Institute of Nursing Research (NINR)CompletedSurgery | Surgery--Complications | Perioperative/Postoperative ComplicationsUnited States
-
Yale UniversityRecruitingPostoperative Complications (Cardiopulmonary)United States
-
Vastra Gotaland RegionRecruitingSurgery | Lung Infection | Complications, PostoperativeSweden
-
University of PittsburghCompletedLiver Transplant; Complications | Perioperative/Postoperative ComplicationsUnited States
-
Chi Mei Medical HospitalCompletedPostoperative Respiratory Complications | Pain, Postoperative.Taiwan
-
Fujian Medical University Union HospitalNot yet recruitingPostoperative Pulmonary Complications
-
COPAL - My JourneyRecruiting
Clinical Trials on SIL drain
-
NuSirt BiopharmaCompleted
-
HOHM FoundationNot yet recruitingSilicosisUnited States
-
Biossil Inc.Not yet recruitingSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Anaemia
-
Linkoeping UniversityLund UniversityRecruiting
-
Zuyderland Medisch CentrumRecruitingBreast Cancer | Seroma | Wound ComplicationNetherlands
-
Stanford UniversityIC Surgical, Inc.RecruitingMastectomy | Implant Based Breast ReconstructionUnited States
-
Mert ÖzcanCompletedChondropathy | Knee Effusion | Knee Hemarthrosis
-
University of Roma La SapienzaCompleted
-
Colorado Joint ReplacementUniversity of Colorado, Denver; Centura HealthCompletedOsteoarthritis | Bilateral Total Knee ArthroplastyUnited States